ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CVM Cel Sci Corporation New

2.06
0.05 (2.49%)
Mar 18 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Cel Sci Corporation New CVM AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.05 2.49% 2.06 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.06 2.00 2.09 2.05 2.01
more quote information »

Recent News

Date Time Source Heading
3/18/20248:51IHNWFeaturedElevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
3/18/20248:09IHNWFeaturedProspera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation
3/07/202411:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
3/07/202411:33EDGAR2Form ARS - Annual Report to Security Holders
3/06/202408:45BWCEL-SCI Corporation Issues Letter to Shareholders
2/15/202408:00BWCEL-SCI Corporation Reports First Quarter Fiscal 2024..
2/14/202416:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/13/202412:00BWCEL-SCI Announces Closing of $7.75 Million Public Offering..
2/09/202408:30BWCEL-SCI Announces Pricing of $7.75 Million Public Offering..
2/06/202409:00BWCEL-SCI Completes Commissioning of Its Multikine..
1/31/202409:00BWEuropean Medicines Agency Grants CEL-SCI a Waiver of Strict..
1/02/202409:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/02/202409:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/02/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/22/202316:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/22/202308:00BWCEL-SCI Reports Fiscal 2023 Financial Results and Clinical &..
12/21/202316:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
12/04/202308:30BWUK’S National Institute for Health and Care Excellence..
11/20/202317:25EDGAR2Form 8-K - Current report
11/20/202316:15BWCEL-SCI Announces Closing of $5 Million Public Offering of..
11/16/202308:30BWCEL-SCI Announces Pricing of $5 Million Offering of Common..
10/30/202317:01EDGAR2Form 8-K - Current report
10/30/202309:20BWCEL-SCI Issues Letter to Shareholders
10/24/202310:18EDGAR2Form 8-K - Current report
10/24/202308:00BWCEL-SCI Releases Video Detailing Recent Phase 3 Findings &..
10/23/202309:15BW5-Year Head & Neck Cancer Survival Increased From 45% to 73%..
10/19/202308:00BWCEL-SCI Readies Its Multikine Manufacturing Facility for..
10/05/202308:45BWCEL-SCI Files Request With the UK’s MHRA Regarding Path to..
10/03/202310:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202310:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202310:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/26/202309:00BWCEL-SCI Submits Scientific Advice Filing to European..
8/31/202317:16EDGAR2Form 8-K - Current report
8/11/202308:00BWCEL-SCI Corporation Reports Third Quarter Fiscal 2023..
8/10/202316:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/20/202316:10EDGAR2Form 8-K - Current report
7/20/202311:36BWCEL-SCI Announces Closing of Public Offering
7/18/202316:05EDGAR2Form 8-K - Current report
7/17/202321:23BWCEL-SCI Announces Pricing of Public Offering
7/17/202316:05BWCEL-SCI Announces Proposed Public Offering of Common Stock
7/14/202312:25EDGAR2Form 8-K - Current report
7/14/202309:15BWCEL-SCI Concludes Positive Meeting With U.S. FDA Concerning..
7/12/202309:01EDGAR2Form 8-K - Current report
7/11/202308:45BWCEL-SCI Reports Phase 3 Tumor PD-L1 Biomarker Data..

Your Recent History

Delayed Upgrade Clock